The company decided to scrap the Orion-17 trial of its cholesterol-lowering drug Leqvio, involving 40,000 patients in partnership with NHS England. The Guardian
Thursday 23 March 2023
Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions
Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions The Swiss pharmaceutical firm Novartis has ditched plans for a large clinical trial in the UK, in a further blow to the government’s efforts to make Britain an attractive place for research and investment after Brexit.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment